The First Report of Endoscopic Ultrasound-guided Intralesional Rituximab in a Patient With Mantle Cell Lymphoma Presenting With Isolated Colorectal Involvement

Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):e485-e487. doi: 10.1016/j.clml.2020.03.002. Epub 2020 Mar 16.

Authors

Emily Fay¹, Daniel Herzig², Kaveh Sharzehi³, Stephen E Spurgeon⁴

Affiliations

¹ Department of Hematology and Oncology, Oregon Health and Science University, Portland, OR. Electronic address: fayem@ohsu.edu.
² Department of Gastrointestinal and General Surgery, Oregon Health and Science University, Portland, OR.
³ Department of Gastroenterology and Hepatology, Oregon Health and Science University, Portland, OR.
⁴ Department of Hematology and Oncology, Oregon Health and Science University, Portland, OR.

PMID: 32278675
DOI: 10.1016/j.clml.2020.03.002

No abstract available

Keywords: B-cell neoplasm; Immunotherapy; Intralesional therapy; Lymphoid neoplasms; Malignant hematology.

Publication types

Case Reports

MeSH terms

Colorectal Neoplasms / physiopathology*
Endoscopy / methods*
Humans
Lymphoma, Mantle-Cell / complications
Lymphoma, Mantle-Cell / diagnostic imaging*
Lymphoma, Mantle-Cell / pathology
Male
Middle Aged
Rituximab / pharmacology
Rituximab / therapeutic use*
Ultrasonography, Interventional / methods*

Substances

Rituximab